Biden Administration Launches Office for Long COVID Research
Medically reviewed by Drugs.com.
By Cara Murez HealthDay Reporter
TUESDAY, Aug. 1, 2023 -- As Americans continue to grapple with the effects of long COVID, the Biden administration on Monday announced the creation of a new office focused on research about the condition that will be part of the U.S. Department of Health and Human Services.
The Office of Long COVID Research and Practice will lead the U.S. response to long COVID, which incudes trials that have already been launched, the HHS said in an agency news release.
“As our nation continues to make strides in combating COVID-19, it is crucial that we address the impact of long COVID and provide resources to those in need,” said HHS Secretary Xavier Becerra. “Last year, President Biden called on HHS to coordinate the response to long COVID. The official establishment of the Long COVID Coordinating office and the launch of the RECOVER clinical trials solidifies this issue as an ongoing priority.”
The $1.15 billion RECOVER research program is meant to better understand, treat and prevent long COVID; as many as 23 million Americans have developed the condition, according to HHS estimates.
Research has identified 12 possible symptoms of long COVID, including worsening of health after mental or physical activity, fatigue, brain fog and dizziness, changes in taste or smell, thirst and changes in sexual desire or capacity. It can also include gastrointestinal symptoms, heart palpitations, chronic cough, chest pain and abnormal movements.
These are among more than 200 symptoms that have been associated with long COVID.
“The Office of Long COVID Research and Practice will enhance efforts being undertaken across the U.S. government to improve the lives of those who continue to experience the long-term impacts of the worst public health crisis in a century,” said HHS Assistant Secretary of Health Adm. Dr. Rachel Levine, who will lead the new research effort. “Bringing together the resources and expertise of federal, state and local partners, patients, providers, researchers and the business sector to answer the American peoples' most urgent calls to action.”
Sources
- Department of Health and Human Services, news release, July 31, 2023
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted August 2023
Further Support and Information on COVID-19
Read this next
CDC Advises Updated COVID Vaccine for Everyone Over 6 Months of Age
FRIDAY, June 28, 2024 -- As a summer wave of COVID infections rolls across the country, U.S. health officials have recommended that all Americans over the age of 6 months get one...
Childhood Exposure to Air Pollution May Trigger Bronchitis Years Later
FRIDAY, June 28, 2024 -- Exposure to air pollution as a child increases an adult’s risk of bronchitis, a new study warns. Young adults with bronchitis symptoms tended to...
Bird Flu Virus Stays Active on Cow Milking Equipment for at Least One Hour
FRIDAY, June 28, 2024 -- The spread of H5N1 avian flu to dairy cows has health experts and many Americans on edge, and now a new study finds the virus stays viable on milking...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.